What information do physicians receive from pharmaceutical representatives?

Canadian Family Physician

Volumn 43, Issue MAY, 1997, Pages 941-945

  Lexchin, Joel ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; CANADA; CLINICAL PRACTICE; DRUG INDUSTRY; DRUG INFORMATION; DRUG UTILIZATION; FINLAND; HUMAN; MEDICAL EDUCATION; METHODOLOGY; PRESCRIPTION; REVIEW; UNITED STATES;

AUSTRALIA; CANADA; DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUG UTILIZATION; EDUCATION, MEDICAL, CONTINUING; FINLAND; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; RESEARCH DESIGN; UNITED STATES;

EID: 0031136577     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Williams AP, Cockerill R. Report on the 1989 survey of the prescribing experiences and attitudes toward prescription drugs of Ontario physicians. Research report. Toronto: Pharmaceutical Inquiry of Ontario; 1990.
2. Shin JH, Haynes RB, Johnston ME. Effect of problem-based, self-directed undergraduate education on life-long learning. Can Med Assoc J 1993;148:969-76.
3. Angus Reid Group. Credibility and the marketing mix. Toronto: Angus Reid Group; 1991.
4. Lurie N, Rich EC, Simpson DE, Meyer J, Schiedermayer DL, Goodman JL, et al. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med 1990;5:240-3.
5. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. Can Med Assoc J 1995;153:553-9.
6. Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc Sci Med 1988;26:1183-9.
7. Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994;271:684-9.
8. Pharmacoeconomics dilemma for FDA. Scrip Newslett 1994;(1961):10.
9. Pharmaceutical Manufacturers Association of Canada. Code of marketing practices. Ottawa: PMAC, 1994.
10. Gordon M. "Disinformation" from pharmaceutical company representatives [letter]. Can Med Assoc J 1990;142:1177-8.
11. Swanson RW. Three cheers for CME? [letter] Can Med Assoc J 1992;146:1519.
12. Hemminki E. Content analysis of drug-detailing by pharmaceutical representatives. Med Educ 1977;11:210-5.
13. Hemminki E. Commercial information on drugs: confusing the physician. J Drug Issues 1988;18:245-57.
14. Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sales representatives. JAMA 1995; 273:1296-8.
15. Roughead EE. The pharmaceutical representative and medical practitioner encounter - implications for quality use of medicine [MSc thesis]. Bundoora, Australia: LaTrobe University; August 1995.
16. Physicians' Desk Reference. 47th ed. Montvale, NJ: Medical Economics Data; 1993.
17. Blondeel L, Cannoodt L, DeMeyeere M, Proesmans H. Prescription behaviour of 358 Flemish general practitioners. Paper presented at the International Society of General Medicine meeting, Prague, Spring 1987.
18. Greenwood J. Pharmaceutical representatives and the prescribing of drugs by family doctors [PhD thesis]. Nottingham, Engl: Nottingham University; 1989.
19. Becker MH, Stolley PD, Lasagna L, McEvilla JD, Sloane LM. Differential education concerning therapeutics and resultant physician prescribing patterns. J Med Educ 1972;47:118-27.
20. Bower AD, Burkett GL. Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices. J Fam Pract 1987;24:612-6.
21. Spingarn RW, Berlin JA, Strom BL. When pharmaceutical manufacturers' employees present grand rounds, what do residents remember? Acad Med 1996; 71:86-8.
22. Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives and the cost of prescribing. Arch Fam Med 1996;5:201-6.
23. Gray J, editor. Therapeutic choices. Ottawa: Canadian Pharmaceutical Association; 1995.
24. Levine M, Lexchin J, Pellizzari R, editors. Drugs of choice: a formulary for general practice. Ottawa: Canadian Medical Association, 1995.